Barclays Analysts Give AXA (EPA:CS) a €29.00 Price Target

AXA (EPA:CS) has been given a €29.00 ($33.72) price target by Barclays in a report released on Wednesday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. Barclays‘s target price suggests a potential upside of 18.44% from the stock’s current price.

A number of other brokerages have also recently weighed in on CS. Morgan Stanley set a €26.70 ($31.05) price target on shares of AXA and gave the company a “buy” rating in a research report on Tuesday, August 6th. Nord/LB set a €27.00 ($31.40) price objective on shares of AXA and gave the stock a “buy” rating in a research report on Tuesday, August 27th. JPMorgan Chase & Co. set a €26.90 ($31.28) price objective on shares of AXA and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Deutsche Bank set a €25.00 ($29.07) target price on shares of AXA and gave the company a “buy” rating in a research note on Thursday, November 7th. Finally, Goldman Sachs Group set a €29.00 ($33.72) target price on shares of AXA and gave the company a “buy” rating in a report on Monday. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of €27.10 ($31.51).

CS opened at €24.49 ($28.47) on Wednesday. The firm has a 50 day moving average price of €24.53 and a 200 day moving average price of €23.08. AXA has a 1 year low of €22.13 ($25.73) and a 1 year high of €27.69 ($32.20).

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Read More: Economic Bubble

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.